Praveen Kumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Praveen Kumar has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Induni Nayodhara Weerarathna
Department of Biomedical Sciences, Datta Meghe Institute of Higher Education and Research (Deemed to be University), Wardha, Maharashtra, 442001, India
3 shared publications Swapnil Gundewar
Department of Artificial Intelligence and Machine Learning, Faculty of Engineering and Technology, Datta Meghe Institute of Higher Education and Research (Deemed to Be University), Wardha, India
3 shared publications- Anurag Luharia
Datta Meghe Institute of Higher Education and Research, India
2 shared publications - Gaurav Vedprakash Mishra
Datta Meghe Institute of Higher Education and Research, Wardha, India
2 shared publications - Mansi Sharma
Faculty of Engineering and Technology, Datta Meghe Institute of Higher Education and Research, Wardha Maharashtra, India
2 shared publications Prateek Verma
Department of Artificial Intelligence and Machine Learning, Faculty of Engineering and Technology, Datta Meghe Institute of Higher Education and Research (Deemed to Be University), Wardha, India
2 shared publications
Latest Publications
- 18 July 2025
- Published by IGI Global Scientific Publishing
- p. 41-64
Decoding MRI Data Machine Learning for Structural Biomarker Discovery in Modern Radiodiagnosis
MRI systems have been described as providing full anatomic and physiologic functional information regarding the human body, and in that regard, it can be said that MRI systems have transformed the field of Medical Imaging. On the other hand, it is still a hard to extract insightful information from MRI, for the most part its data handling and storage capabilities have still not been utilized to its fullest. However, New structural biomarkers surfaced due to the automation and augmentation of MRI data interpretation by machine learning (ML) methods, particularly deep learning as a subfield of ML. In this chapter we aim to apply ML tools to identify structural biomarkers in the context of MRI and its applications for radiodiagnosis. For that as a start we review the challenges involved in the analysis of standard MRI images which include the need of expert intervention after scanning, high volume and variability of images as well as the quantitative aspects of the images.
- 18 July 2025
- Published by IGI Global Scientific Publishing
- p. 41-64
Decoding MRI Data Machine Learning for Structural Biomarker Discovery in Modern Radiodiagnosis
MRI systems have been described as providing full anatomic and physiologic functional information regarding the human body, and in that regard, it can be said that MRI systems have transformed the field of Medical Imaging. On the other hand, it is still a hard to extract insightful information from MRI, for the most part its data handling and storage capabilities have still not been utilized to its fullest. However, New structural biomarkers surfaced due to the automation and augmentation of MRI data interpretation by machine learning (ML) methods, particularly deep learning as a subfield of ML. In this chapter we aim to apply ML tools to identify structural biomarkers in the context of MRI and its applications for radiodiagnosis. For that as a start we review the challenges involved in the analysis of standard MRI images which include the need of expert intervention after scanning, high volume and variability of images as well as the quantitative aspects of the images.
- Open Access
- 22 April 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (9) , 4637
Integrating Machine Learning Algorithms: A Hybrid Model for Lung Cancer Outcome Improvement
Lung cancer is a major global health threat, affecting millions annually and resulting in severe complications and high mortality rates, particularly when diagnosed late. It remains one of the leading causes of cancer-related deaths worldwide, often detected at advanced stages due to the lack of early symptoms. This study introduces a novel hybrid machine learning model aimed at enhancing early detection accuracy and improving patient outcomes. By integrating traditional machine learning classifiers with deep learning techniques, the proposed framework optimizes feature selection, hyperparameter tuning, and data-balancing strategies, such as Adaptive Synthetic Sampling (ADASYN). A comparative evaluation with existing models demonstrated substantial improvements in predictive accuracy, ranging from 0.44% to 9.69%, with Gradient Boosting and Random Forest models achieving the highest classification performance. The study highlights the importance of hybrid methodologies in refining lung cancer diagnostics, ensuring robust, scalable, and clinically viable predictive models.
- 22 April 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (9) , 4637
Open AccessIntegrating Machine Learning Algorithms: A Hybrid Model for Lung Cancer Outcome Improvement
Lung cancer is a major global health threat, affecting millions annually and resulting in severe complications and high mortality rates, particularly when diagnosed late. It remains one of the leading causes of cancer-related deaths worldwide, often detected at advanced stages due to the lack of early symptoms. This study introduces a novel hybrid machine learning model aimed at enhancing early detection accuracy and improving patient outcomes. By integrating traditional machine learning classifiers with deep learning techniques, the proposed framework optimizes feature selection, hyperparameter tuning, and data-balancing strategies, such as Adaptive Synthetic Sampling (ADASYN). A comparative evaluation with existing models demonstrated substantial improvements in predictive accuracy, ranging from 0.44% to 9.69%, with Gradient Boosting and Random Forest models achieving the highest classification performance. The study highlights the importance of hybrid methodologies in refining lung cancer diagnostics, ensuring robust, scalable, and clinically viable predictive models.
- Top Cited PapersOpen Access
- 3 January 2025
- Published by Springer Nature in Molecular Biomedicine
- Vol. 6 (1) , 1-25
The role of artificial intelligence in pandemic responses: from epidemiological modeling to vaccine development
Integrating Artificial Intelligence (AI) across numerous disciplines has transformed the worldwide landscape of pandemic response. This review investigates the multidimensional role of AI in the pandemic, which arises as a global health crisis, and its role in preparedness and responses, ranging from enhanced epidemiological modelling to the acceleration of vaccine development. The confluence of AI technologies has guided us in a new era of data-driven decision-making, revolutionizing our ability to anticipate, mitigate, and treat infectious illnesses. The review begins by discussing the impact of a pandemic on emerging countries worldwide, elaborating on the critical significance of AI in epidemiological modelling, bringing data-driven decision-making, and enabling forecasting, mitigation and response to the pandemic. In epidemiology, AI-driven epidemiological models like SIR (Susceptible-Infectious-Recovered) and SIS (Susceptible-Infectious-Susceptible) are applied to predict the spread of disease, preventing outbreaks and optimising vaccine distribution. The review also demonstrates how Machine Learning (ML) algorithms and predictive analytics improve our knowledge of disease propagation patterns. The collaborative aspect of AI in vaccine discovery and clinical trials of various vaccines is emphasised, focusing on constructing AI-powered surveillance networks. Conclusively, the review presents a comprehensive assessment of how AI impacts epidemiological modelling, builds AI-enabled dynamic models by collaborating ML and Deep Learning (DL) techniques, and develops and implements vaccines and clinical trials. The review also focuses on screening, forecasting, contact tracing and monitoring the virus-causing pandemic. It advocates for sustained research, real-world implications, ethical application and strategic integration of AI technologies to strengthen our collective ability to face and alleviate the effects of global health issues.
- 3 January 2025
- Published by Springer Nature in Molecular Biomedicine
- Vol. 6 (1) , 1-25
Top Cited PapersOpen AccessThe role of artificial intelligence in pandemic responses: from epidemiological modeling to vaccine development
Integrating Artificial Intelligence (AI) across numerous disciplines has transformed the worldwide landscape of pandemic response. This review investigates the multidimensional role of AI in the pandemic, which arises as a global health crisis, and its role in preparedness and responses, ranging from enhanced epidemiological modelling to the acceleration of vaccine development. The confluence of AI technologies has guided us in a new era of data-driven decision-making, revolutionizing our ability to anticipate, mitigate, and treat infectious illnesses. The review begins by discussing the impact of a pandemic on emerging countries worldwide, elaborating on the critical significance of AI in epidemiological modelling, bringing data-driven decision-making, and enabling forecasting, mitigation and response to the pandemic. In epidemiology, AI-driven epidemiological models like SIR (Susceptible-Infectious-Recovered) and SIS (Susceptible-Infectious-Susceptible) are applied to predict the spread of disease, preventing outbreaks and optimising vaccine distribution. The review also demonstrates how Machine Learning (ML) algorithms and predictive analytics improve our knowledge of disease propagation patterns. The collaborative aspect of AI in vaccine discovery and clinical trials of various vaccines is emphasised, focusing on constructing AI-powered surveillance networks. Conclusively, the review presents a comprehensive assessment of how AI impacts epidemiological modelling, builds AI-enabled dynamic models by collaborating ML and Deep Learning (DL) techniques, and develops and implements vaccines and clinical trials. The review also focuses on screening, forecasting, contact tracing and monitoring the virus-causing pandemic. It advocates for sustained research, real-world implications, ethical application and strategic integration of AI technologies to strengthen our collective ability to face and alleviate the effects of global health issues.
- Open Access
- 11 November 2024
- Published by Springer Nature in Molecular Biomedicine
- Vol. 5 (1) , 1-30
Prophylactic and therapeutic vaccine development: advancements and challenges
Biomedical research is fundamental in developing preventive and therapeutic vaccines, serving as a cornerstone of global public health. This review explores the key concepts, methodologies, tools, and challenges in the vaccine development landscape, focusing on transitioning from basic biomedical sciences to clinical applications. Foundational disciplines such as virology, immunology, and molecular biology lay the groundwork for vaccine creation, while recent innovations like messenger RNA (mRNA) technology and reverse vaccinology have transformed the field. Additionally, it highlights the role of pharmaceutical advancements in translating lab discoveries into clinical solutions. Techniques like CRISPR-Cas9, genome sequencing, monoclonal antibodies, and computational modeling have significantly enhanced vaccine precision and efficacy, expediting the development of vaccines against infectious diseases. The review also discusses challenges that continue to hinder progress, including stringent regulatory pathways, vaccine hesitancy, and the rapid emergence of new pathogens. These obstacles underscore the need for interdisciplinary collaboration and the adoption of innovative strategies. Integrating personalized medicine, nanotechnology, and artificial intelligence is expected to revolutionize vaccine science further. By embracing these advancements, biomedical research has the potential to overcome existing challenges and usher in a new era of therapeutic and prophylactic vaccines, ultimately improving global health outcomes. This review emphasizes the critical role of vaccines in combating current and future health threats, advocating for continued investment in biomedical science and technology.
- 11 November 2024
- Published by Springer Nature in Molecular Biomedicine
- Vol. 5 (1) , 1-30
Open AccessProphylactic and therapeutic vaccine development: advancements and challenges
Biomedical research is fundamental in developing preventive and therapeutic vaccines, serving as a cornerstone of global public health. This review explores the key concepts, methodologies, tools, and challenges in the vaccine development landscape, focusing on transitioning from basic biomedical sciences to clinical applications. Foundational disciplines such as virology, immunology, and molecular biology lay the groundwork for vaccine creation, while recent innovations like messenger RNA (mRNA) technology and reverse vaccinology have transformed the field. Additionally, it highlights the role of pharmaceutical advancements in translating lab discoveries into clinical solutions. Techniques like CRISPR-Cas9, genome sequencing, monoclonal antibodies, and computational modeling have significantly enhanced vaccine precision and efficacy, expediting the development of vaccines against infectious diseases. The review also discusses challenges that continue to hinder progress, including stringent regulatory pathways, vaccine hesitancy, and the rapid emergence of new pathogens. These obstacles underscore the need for interdisciplinary collaboration and the adoption of innovative strategies. Integrating personalized medicine, nanotechnology, and artificial intelligence is expected to revolutionize vaccine science further. By embracing these advancements, biomedical research has the potential to overcome existing challenges and usher in a new era of therapeutic and prophylactic vaccines, ultimately improving global health outcomes. This review emphasizes the critical role of vaccines in combating current and future health threats, advocating for continued investment in biomedical science and technology.
- 1 October 2024
- Published by IGI Global Scientific Publishing
- p. 29-50
Leveraging AI and Machine Learning for Predictive Analytics in Business Intelligence
In today's tech landscape, business intelligence (BI) is essential, especially with advanced technologies emerging. This study delves into the transformative potential of artificial intelligence and machine learning in predictive analytics, offering crucial insights into data. The chapter provides an extensive overview, focusing on the future of predictive analytics in BI. It highlights real-time applications, featuring practical work and case studies. Key practices for integrating AI and predictive analytics are introduced, covering data preparation, cleaning, preprocessing, feature engineering, and exploratory data analysis. Integration of ML with BI facilitates visualization, report generation, interactive dashboards, and real-time monitoring. However, manual analysis of complex datasets poses challenges, risking valuable insights. This chapter explores how ML automates the identification of patterns, extracting insights. Key challenges and advantages in integrating machine learning into BI frameworks are also discussed.
- 1 October 2024
- Published by IGI Global Scientific Publishing
- p. 29-50
Leveraging AI and Machine Learning for Predictive Analytics in Business Intelligence
In today's tech landscape, business intelligence (BI) is essential, especially with advanced technologies emerging. This study delves into the transformative potential of artificial intelligence and machine learning in predictive analytics, offering crucial insights into data. The chapter provides an extensive overview, focusing on the future of predictive analytics in BI. It highlights real-time applications, featuring practical work and case studies. Key practices for integrating AI and predictive analytics are introduced, covering data preparation, cleaning, preprocessing, feature engineering, and exploratory data analysis. Integration of ML with BI facilitates visualization, report generation, interactive dashboards, and real-time monitoring. However, manual analysis of complex datasets poses challenges, risking valuable insights. This chapter explores how ML automates the identification of patterns, extracting insights. Key challenges and advantages in integrating machine learning into BI frameworks are also discussed.
- Open Access
- 26 September 2024
- Published by MDPI AG in Preprints.org
Sustainable Biomaterials for Pharmaceutical and Medical Applications
The utilization of sustainable biomaterials in pharmaceutical and medical applications has garnered significant attention in recent years due to their potential to address environmental concerns while meeting the demands of modern healthcare. This review provides a comprehensive overview of the latest advancements and applications of sustainable biomaterials in the pharmaceutical and medical fields. Beginning with an exploration of sustainable sourcing methods and production techniques, the review highlights the importance of eco-friendly practices in biomaterial development. Subsequently, it delves into the diverse range of sustainable biomaterials, including biopolymers, natural extracts, and bio-based nanoparticles, elucidating their properties and biomedical applications. Moreover, the chapter discusses the role of sustainable biomaterials in drug delivery systems, tissue engineering, wound healing, and medical device fabrication, emphasizing their biocompatibility, biodegradability, and therapeutic efficacy. Along with discussions on regulatory issues and commercialization prospects, the potential and challenges related to the integration of sustainable biomaterials into pharmaceutical and medical practices are also critically reviewed. By elucidating the advancements and potential of sustainable biomaterials, this article aims to inspire further research and innovation in the pursuit of environmentally friendly and effective solutions for healthcare applications.
- 26 September 2024
- Published by MDPI AG in Preprints.org
Open AccessSustainable Biomaterials for Pharmaceutical and Medical Applications
The utilization of sustainable biomaterials in pharmaceutical and medical applications has garnered significant attention in recent years due to their potential to address environmental concerns while meeting the demands of modern healthcare. This review provides a comprehensive overview of the latest advancements and applications of sustainable biomaterials in the pharmaceutical and medical fields. Beginning with an exploration of sustainable sourcing methods and production techniques, the review highlights the importance of eco-friendly practices in biomaterial development. Subsequently, it delves into the diverse range of sustainable biomaterials, including biopolymers, natural extracts, and bio-based nanoparticles, elucidating their properties and biomedical applications. Moreover, the chapter discusses the role of sustainable biomaterials in drug delivery systems, tissue engineering, wound healing, and medical device fabrication, emphasizing their biocompatibility, biodegradability, and therapeutic efficacy. Along with discussions on regulatory issues and commercialization prospects, the potential and challenges related to the integration of sustainable biomaterials into pharmaceutical and medical practices are also critically reviewed. By elucidating the advancements and potential of sustainable biomaterials, this article aims to inspire further research and innovation in the pursuit of environmentally friendly and effective solutions for healthcare applications.
- Open Access
- 16 September 2024
- Published by Taylor & Francis in Bioengineered
- Vol. 15 (1) , 2401269
Engineering with Biomedical Sciences Changing the Horizon of Healthcare-A Review
In the dynamic realm of healthcare, the convergence of engineering and biomedical sciences has emerged as a pivotal frontier. In this review we go into specific areas of innovation, including medical imaging and diagnosis, developments in biomedical sensors, and drug delivery systems. Wearable biosensors, non-wearable biosensors, and biochips, which include gene chips, protein chips, and cell chips, are all included in the scope of the topic that pertains to biomedical sensors. Extensive research is conducted on drug delivery systems, spanning topics such as the integration of computer modeling, the optimization of drug formulations, and the design of delivery devices. Furthermore, the paper investigates intelligent drug delivery methods, which encompass stimuli-responsive systems such as temperature, redox, pH, light, enzyme, and magnetic responsive systems. In addition to that, the review goes into topics such as tissue engineering, regenerative medicine, biomedical robotics, automation, biomechanics, and the utilization of green biomaterials. The purpose of this analysis is to provide insights that will enhance continuing research and development efforts in engineering-driven biomedical breakthroughs, ultimately contributing to the improvement of healthcare. These insights will be provided by addressing difficulties and highlighting future prospects.
- 16 September 2024
- Published by Taylor & Francis in Bioengineered
- Vol. 15 (1) , 2401269
Open AccessEngineering with Biomedical Sciences Changing the Horizon of Healthcare-A Review
In the dynamic realm of healthcare, the convergence of engineering and biomedical sciences has emerged as a pivotal frontier. In this review we go into specific areas of innovation, including medical imaging and diagnosis, developments in biomedical sensors, and drug delivery systems. Wearable biosensors, non-wearable biosensors, and biochips, which include gene chips, protein chips, and cell chips, are all included in the scope of the topic that pertains to biomedical sensors. Extensive research is conducted on drug delivery systems, spanning topics such as the integration of computer modeling, the optimization of drug formulations, and the design of delivery devices. Furthermore, the paper investigates intelligent drug delivery methods, which encompass stimuli-responsive systems such as temperature, redox, pH, light, enzyme, and magnetic responsive systems. In addition to that, the review goes into topics such as tissue engineering, regenerative medicine, biomedical robotics, automation, biomechanics, and the utilization of green biomaterials. The purpose of this analysis is to provide insights that will enhance continuing research and development efforts in engineering-driven biomedical breakthroughs, ultimately contributing to the improvement of healthcare. These insights will be provided by addressing difficulties and highlighting future prospects.
- Open Access
- 1 January 2024
- Published by American Institute of Mathematical Sciences (AIMS) in AIMS Bioengineering
- Vol. 11 (3) , 343-390
Human–computer interaction in healthcare: Comprehensive review
Technological advancements have fundamentally transformed healthcare systems and significantly altered the interactions between medical professionals and information interfaces. This study provides a comprehensive review of the role of human–computer interaction (HCI) in healthcare, emphasizing the importance of user-centered design and the integration of emerging technologies. The paper reviews the evolution of healthcare interfaces, exploring key assumptions in foundational HCI principles and theoretical frameworks that guide the design processes. The analysis delves into the application of HCI principles, particularly user-centered approaches, to enhance feedback mechanisms, ensure consistency, and improve visibility within medical settings, all of which contribute to creating practical, usable, and memorable interfaces. The review provides an overview of successful and unsuccessful cases, demonstrating what determines efficacy in healthcare interface design. The discussion extends to cover the role of interactive interfaces in streamlining clinical workflows, facilitating communication and collaboration, and supporting informed decision-making among healthcare providers. This paper focuses on historical views and milestones of interface design, emphasizing the significance of interactive interfaces. The discussion extends to cover the role of interactive interfaces in streamlining clinical workflows, facilitating communication and collaboration, and supporting informed decision-making among healthcare providers. Further, the review concludes with an examination of future trends in HCI for healthcare, particularly focusing on the rapid integration of emerging technologies and their implications for the ongoing evolution of interface design in this critical field.
- 1 January 2024
- Published by American Institute of Mathematical Sciences (AIMS) in AIMS Bioengineering
- Vol. 11 (3) , 343-390
Open AccessHuman–computer interaction in healthcare: Comprehensive review
Technological advancements have fundamentally transformed healthcare systems and significantly altered the interactions between medical professionals and information interfaces. This study provides a comprehensive review of the role of human–computer interaction (HCI) in healthcare, emphasizing the importance of user-centered design and the integration of emerging technologies. The paper reviews the evolution of healthcare interfaces, exploring key assumptions in foundational HCI principles and theoretical frameworks that guide the design processes. The analysis delves into the application of HCI principles, particularly user-centered approaches, to enhance feedback mechanisms, ensure consistency, and improve visibility within medical settings, all of which contribute to creating practical, usable, and memorable interfaces. The review provides an overview of successful and unsuccessful cases, demonstrating what determines efficacy in healthcare interface design. The discussion extends to cover the role of interactive interfaces in streamlining clinical workflows, facilitating communication and collaboration, and supporting informed decision-making among healthcare providers. This paper focuses on historical views and milestones of interface design, emphasizing the significance of interactive interfaces. The discussion extends to cover the role of interactive interfaces in streamlining clinical workflows, facilitating communication and collaboration, and supporting informed decision-making among healthcare providers. Further, the review concludes with an examination of future trends in HCI for healthcare, particularly focusing on the rapid integration of emerging technologies and their implications for the ongoing evolution of interface design in this critical field.